Sunday, 21 July 2019

India News

  • Asia vaccine strategists call for collaboration

    India |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply for public health, and stronger partnership between international pl...Read more

  • CSIR head: Indian bioscience education disappoints me

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 May, 2013

    In 2002, biotechnology was just in its nascent stage and was considered to be a small industry. However, the success story of the vaccine sector and the emergence of companies such as Bhara...Read more

  • Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand, to leverage and maximize the synergies of the Hybrid Business Model...Read more

  • Ninad Deshpanday is Kemwell R&D president

    India |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

    Bangalore: India-based Kemwell Biopharma appointed Dr Ninad Deshpanday as president of R&D. Dr Deshpanday has over 22 years of experience in diverse international roles in the pharmaceu...Read more

  • NeuClone, Serum Institute join hands

    India |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

    Singapore: Sydney-based biotechnology firm, NeuClone has signed a major licensing agreement and joint development partnership with The Serum Institute of India. The deal will cover the manu...Read more

  • 'Novartis focuses on new products, business growth'

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Novartis India has over the past year launched three successful patented drugs and over 12 generic drugs. They have helped it expand its presence in the country. "Glivec is behin...Read more

  • Victoria is on mission to tap the Indian market

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2013

    Hyderabad: BioAsia 2013, which was held recently from January 28-30, 2013, at Hyderabad, India, saw participation from 500 representatives from 45 countries. One-of-the-delegations that att...Read more

  • US FDA warns Apotex's Indian facility

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: United States Federal Drug Approval (USFDA) has issued a letter to the COO of Apotex Mr Jeremy B Desai. Th letter was issued after investigators identified significant deviations...Read more

  • Fortis to elevate healthcare delivery with Next-gen hospital

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Fortis Healthcare has come up with its vision for the next generation hospital, the 'Fortis Memorial Research Institute. The hospital is expected to open shortly in Gurgaon, Ind...Read more

  • Indian pharma clocks 8.9% growth in June 2013: IMS

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

    New Delhi: The IMS Health Total Sales Audit (TSA) has released a report stating that the Indian pharmaceutical market has clocked a growth of 8.9 percent during the month of June 2013. The...Read more

  • Fortis pioneers new minimal invasive surgery

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: In a press conference announcing a second successful experimental minimally invasive cardiovascular bypass surgery, Dr Vivek Jawali, chairman, Cardiovascular sciences, Fortis hos...Read more

  • Cliantha uses Acceliant software to manage trials

    India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2013

    Singapore: India based contract research organization (CRO), Cliantha Research has implemented Acceliant's eClinical Suite for their clinical trial data management needs. Acceliant is the m...Read more

  • Merck unveils solid dose formulation lab

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: According to Merck's press release, the facilities at the lab were built to provide services and application assistance to the pharmaceutical industry, for classic pharmaceutical...Read more

  • Ranbaxy advisory: All our products are safe and efficacious

    India |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and efficacious. The firm revealed that the advisory was issued in public i...Read more

  • Tripura Malaria death roll rises to 41

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: "At least 41 people, including 31 children, have died and more than 22,000 have fallen ill since the first week of this month. Of the 22,000 affected people, the malaria germ has...Read more

  • Dr. Reddy's, Merck Serono enter partnership

    India |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2012

    Singapore: Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, have entered into a partnership to co-develop a portfolio of biosimilar compounds in onco...Read more

  • Biological E to supply vaccine to Vacsera of Egypt

    India |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2013

    Singapore: Biological E has entered into a long term supply agreement with Vacsera (and its subsidiary Egyvac), an Egyptian vaccines company under the Ministry of Health of Egypt, for the p...Read more

  • Now Ranbaxy's Mohali unit under FDA scanner

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2013

    Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, selling adulterated drugs in the US and paying a penalty of $500 millio...Read more



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls